Trading Signals: NNVC Stock Price Prediction and Forecast (Thu. Aug. 12, 2004 - Thu. Mar. 25, 2021)(NanoViricides)
| NNVC latest price $25.2000 (2.44%) ($24.6000 - $25.8000) on Thu. Jun. 1, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 3.12% (three month average) | | RSI | 58 | | Latest Price | $25.2000(2.44%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | NNVC declines -1.6% a day on average for past five trading days. | | Weekly Trend | NNVC advances 4% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support NNVC advance at 0% a week (0% probability)
TAN(14%) IVW(12%) JETS(12%) VUG(12%) XLK(12%) | | Factors Impacting NNVC price | NNVC will decline at least -1.56% in a week (0% probabilities).
VIXM(-6%) TLT(-3%) SLV(-3%) BWX(-3%) UNG(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.56% (StdDev 3.12%) | | Hourly BBV | 0 () | | Intraday Trend | 2.4% | | | | | |
|
| 5 Day Moving Average | $26.48(-4.83%) | | 10 Day Moving Average | $26.27(-4.07%) | | 20 Day Moving Average | $25.07(0.52%) | | To recent high | -9.4% | | To recent low | 18.9% | | Market Cap | $193m | | | | | | |
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.July 8, 2020 Clinical observations and gross post-mortem studies have been completed. The tested drug candidates were safe and well tolerated, thereby clearing the path for further development towards a treatment for COVID-19. |